Literature DB >> 14499

Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.

K O Stumpe, R Kolloch, H Vetter, W Gramann, F Krück, C Ressel, M Higuchi.   

Abstract

The antihypertensive effect of intravenous (acute) and oral (long-term) beta-adrenergic blockade with propranolol or pindolol was evaluated in 46 male patients with either borderline (group I; 23 patients) or sustained (group II; 23 patients) essential hypertension. Arterial pressure, plasma renin activity and plasma concentration of aldosterone were determined during continuous recumbency overnight every 30 minutes before and after treatment. Patients of group I exhibited a marked variation of their recumbent plasma renin activity with relatively low values before midnight and large increases early in the morning. In contrast, low plasma renin activity values and only minimal fluctuations in renin were observed in patients of group II. Plasma renin activity had a consistent relationship with blood pressure both after acute (r = 0.79) and long-term (r = 0.4) beta-blockade. In four patients of group I, who had high plasma renin activity and had responded to intravenous propranolol, infusion of angiotensin II inhibitor did not lower pressure. In group I following beta-blockade, day-night profiles of renin were similar to those observed in group II before treatment. Thus in this latter subgroup, low renin profiles might reflect reduced beta-adrenergic activity. Acute as well as long-term beta-blockade consistently eliminated the day-night rhythm of plasma renin activity, but it did not change rhythm of plasma concentration of aldosterone. Plasma concentration of aldosterone was lower in group II but appeared to be inappropriately high relative to renin levels. These observations suggest that in hypertensive patients classified according to blood pressure and recumbent plasma renin activity profiles a significant relationship exists between changes in plasma renin activity and arterial pressure responses. Thus, patients with high renin levels respond better to treatment than patients with low renin levels. We conclude that in the patients studied, sympathetic nervous system activity mainly determined renin levels as well as antihypertensive effectiveness of the beta-blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 14499     DOI: 10.1016/0002-9343(76)90905-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  [Behaviour of plasma renin activity during long-term treatment with propranolol (author's transl)].

Authors:  H Witzgall; D Klaus; B Braun; H Ebel; J Zehner
Journal:  Klin Wochenschr       Date:  1977-04-01

3.  Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  A A Ajayi; N Hockings; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

4.  Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.

Authors:  R Davies; T G Pickering; A Morganti; M Wilson; J H Laragh
Journal:  Br Heart J       Date:  1979-03

5.  Age related antihypertensive effect of nitrendipine, a new calcium entry blocking agent.

Authors:  L A Ferrara; M L Fasano; S Soro
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy.

Authors:  F H Leenen; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

7.  Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

8.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.

Authors:  J F Smits; H van Essen; H A Struyker-Boudier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

10.  Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.

Authors:  Yan Gong; Zhiying Wang; Amber L Beitelshees; Caitrin W McDonough; Taimour Y Langaee; Karen Hall; Siegfried O F Schmidt; Robert W Curry; John G Gums; Kent R Bailey; Eric Boerwinkle; Arlene B Chapman; Stephen T Turner; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  Hypertension       Date:  2016-01-04       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.